Key details
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Enrollment target
~20 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated November 2024